Nordhealth AS - Mandatory Notifications of Trade by Primary Insiders

Helsinki, Finland, 26 March 2026: Charles MacBain, CEO and a primary insider of Nordhealth AS (the "Company"), has today entered into a derivative contract with his close associates, linked to shares in the Company. The derivatives are linked 1:1 with the said shares. Please refer to the attached notifications of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20 This information is subject to disclosure requirements set out in the EU Market Abuse Regulation (EU) No 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12. *** About Nordhealth Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 60,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries. Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with 400 employees working either remotely or from offices (collaboration hubs). Visit the company's website at nordhealth.com(http://www.nordhealth.com).